相似文献
1
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
JAMA. 2022 Apr 5;327(13):1286-1288. doi: 10.1001/jama.2022.2274.
2
SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
JAMA. 2022 Jul 26;328(4):395. doi: 10.1001/jama.2022.9259.
3
SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
JAMA. 2022 Jul 26;328(4):395-396. doi: 10.1001/jama.2022.9262.
4
Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada.
Emerg Infect Dis. 2023 Aug;29(8):1580-1588. doi: 10.3201/eid2908.221580. Epub 2023 Jun 28.
5
Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada.
J Am Med Dir Assoc. 2023 May;24(5):753-758. doi: 10.1016/j.jamda.2023.02.105. Epub 2023 Mar 28.
6
SARS-CoV-2 viral titer measurements in Ontario, Canada wastewaters throughout the COVID-19 pandemic.
Sci Data. 2024 Jun 21;11(1):656. doi: 10.1038/s41597-024-03414-w.
7
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.
JAMA Netw Open. 2022 Sep 1;5(9):e2232760. doi: 10.1001/jamanetworkopen.2022.32760.
8
Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study.
PLoS One. 2023 Mar 31;18(3):e0283715. doi: 10.1371/journal.pone.0283715. eCollection 2023.
9
SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020-January 2022.
Emerg Infect Dis. 2024 May;30(5):956-967. doi: 10.3201/eid3005.230482.
10
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
引用本文的文献
1
Impact of vaccination and SARS-CoV-2 variants on severe COVID-19 outcomes: a cross-sectional study, Brazil, 2021-2022.
Epidemiol Serv Saude. 2025 Sep 1;34:e20240613. doi: 10.1590/S2237-96222025v34e20240613.en. eCollection 2025.
2
Examining epidemiologic disparity across SARS-CoV-2 variant-dominant periods in Oklahoma County, Oklahoma (March 12, 2020-February 28, 2022).
J Public Health Res. 2025 Aug 10;14(3):22799036251363919. doi: 10.1177/22799036251363919. eCollection 2025 Jul.
3
In-hospital mortality in patients admitted to Australian intensive care units with COVID-19 between 2020 and 2024.
Crit Care Resusc. 2025 Feb 28;27(1):100094. doi: 10.1016/j.ccrj.2024.11.003. eCollection 2025 Mar.
4
Clinical characterisation, treatment outcomes, and case fatality risk of patients with different SARS-CoV-2 variants in Bangladesh.
J Glob Health. 2024 Jun 21;14:05009. doi: 10.7189/jogh.14.05009.
5
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024.
Eur Respir Rev. 2025 Feb 19;34(175). doi: 10.1183/16000617.0222-2024. Print 2025 Jan.
6
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrations.
Sci Rep. 2025 Feb 8;15(1):4708. doi: 10.1038/s41598-025-89306-4.
7
Cardiac Damage in Patients Infected with Different SARS-CoV-2 Variants of Concern.
Microorganisms. 2024 Dec 18;12(12):2617. doi: 10.3390/microorganisms12122617.
8
Vulnerability: An Interpretive Descriptive Study of Personal Support Workers' Experiences of Working During the COVID-19 Pandemic in Ontario, Canada.
Healthcare (Basel). 2024 Dec 6;12(23):2474. doi: 10.3390/healthcare12232474.
9
Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey.
Virol J. 2024 Nov 22;21(1):299. doi: 10.1186/s12985-024-02531-7.
10
Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant.
Ann Transl Med. 2024 Oct 20;12(5):87. doi: 10.21037/atm-24-36. Epub 2024 Sep 19.
本文引用的文献
1
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.
Lancet Infect Dis. 2022 Jul;22(7):959-966. doi: 10.1016/S1473-3099(22)00141-4. Epub 2022 Apr 22.
2
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
Lancet. 2022 Jan 29;399(10323):437-446. doi: 10.1016/S0140-6736(22)00017-4. Epub 2022 Jan 19.
3
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
Science. 2022 Feb 18;375(6582):760-764. doi: 10.1126/science.abn7760. Epub 2022 Jan 20.
4
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.
JAMA. 2022 Feb 8;327(6):583-584. doi: 10.1001/jama.2021.24868.
Zotero 插件